Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy of multiple myeloma

Y W Huang1, E S Vitetta

  • 1Cancer Immunobiology Center, University of Texas Southwestern Medical Center, Dallas.

Stem Cells (Dayton, Ohio)
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Mandatory Clinical Ethics Consultation for Neurocritically Ill Patients.

Journal of bioethical inquiry·2026
Same author

Association between Iodized Salt Intake and Cognitive Function in Older Adults in China.

The journal of nutrition, health & aging·2023
Same author

[Visual analysis of the current research status and hotspots of electric burns at home and abroad].

Zhonghua shao shang yu chuang mian xiu fu za zhi·2023
Same author

[Impact of late sodium current inhibition on cardiac electrophysiology parameters and ventricular arrhythmias in isolated Langendorff perfused rabbit hearts with short QT interval].

Zhonghua xin xue guan bing za zhi·2022
Same author

[Effects of obstructive sleep apnea hypopnea syndrome on cardiac function in patients with chronic obstructive pulmonary disease].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases·2022
Same author

Expression of cyclin-dependent kinase subunit 2 in uterine leiomyosarcoma cells.

Journal of biological regulators and homeostatic agents·2019

New immunotherapies offer hope for treating multiple myeloma (MM), a fatal blood cancer. Researchers are exploring novel monoclonal antibodies and cellular therapies to combat this disease where cures remain elusive.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Multiple myeloma (MM) is a fatal plasma cell malignancy with no current cure.
  • Novel therapeutic strategies are urgently needed to improve patient outcomes.
  • Immunotherapy presents a promising avenue for MM treatment.

Purpose of the Study:

  • To review emerging concepts in multiple myeloma immunotherapy.
  • To highlight experimental therapeutic modalities for MM.

Main Methods:

  • Review of existing and investigational immunotherapies for MM.
  • Analysis of monoclonal antibodies targeting IL-6, IL-6R, CD54, B7, HLA-DR, and gp130.
  • Evaluation of adoptive cellular therapies and stem cell transplantation.

Related Experiment Videos

Main Results:

  • Interferons and anti-IL-6 monoclonal antibodies (MAbs) are currently used in MM treatment.
  • Bone marrow transplantation techniques involving MAbs, immunotoxins, and magnetic beads have been reported.
  • Experimental therapies like anti-IL-6R MAbs and IL-6 antagonist proteins show promise in preclinical models.

Conclusions:

  • Current MM treatments are insufficient, necessitating novel approaches.
  • Various immunotherapeutic strategies, including MAbs and cellular therapies, are under investigation.
  • These experimental modalities hold potential for future human MM treatment and offer insights into disease pathogenesis.